We are live on ! Find out more
NVNO

enVVeno Medical
NVNO

22 hedge funds and large institutions have $10.4M invested in enVVeno Medical in 2023 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 5 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

76% more capital invested

Capital invested by funds: $5.9M → $10.4M (+$4.51M)

0% more ownership

Funds ownership: 0.58% → 0.58% (+0%)

4% less funds holding

Funds holding: 23 → 22 (-1)

20% less repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 5

25% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 4

Holders
22
Holders Change
-1
Holders Change %
-4.35%
% of All Funds
0.35%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
4
Reduced
5
Closed
4
Calls
$1.36M
Puts
–
Net Calls
+$1.36M
Net Calls Change
+$1.35M

Top Buyers

Rank Fund Capital Flow
1
UOC
UBS O'Connor
Illinois
+$188K
2
Simplex Trading
Simplex Trading
Illinois
+$84.6K
3
FA
Fermata Advisors
California
+$56.5K
4
Geode Capital Management
Geode Capital Management
Massachusetts
+$45.9K
5
Group One Trading
Group One Trading
Illinois
+$30.4K

Top Sellers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
-$139K
2
Squarepoint
Squarepoint
New York
-$40.9K
3
Renaissance Technologies
Renaissance Technologies
New York
-$36K
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$25K
5
TRCT
Tower Research Capital (TRC)
New York
-$15.2K
Name Holding Trade Value Shares
Change 		Change in
Stake
PA
1
Perceptive Advisors
New York
$4.21M – – –
Vanguard Group
2
Vanguard Group
Pennsylvania
$1.81M – – –
UOC
3
UBS O'Connor
Illinois
$1.22M +$188K +1,128 +21%
KCM
4
Kingdon Capital Management
New York
$1.18M – – –
Geode Capital Management
5
Geode Capital Management
Massachusetts
$500K +$45.9K +275 +12%
Susquehanna International Group
6
Susquehanna International Group
Pennsylvania
$318K -$25K -150 -8%
Morgan Stanley
7
Morgan Stanley
New York
$233K +$30.2K +181 +17%
BlackRock
8
BlackRock
New York
$168K -$12.5K -75 -8%
State Street
9
State Street
Massachusetts
$143K +$24.4K +146 +24%
Dimensional Fund Advisors
10
Dimensional Fund Advisors
Texas
$98.7K – – –
Simplex Trading
11
Simplex Trading
Illinois
$95K +$84.6K +507 New
Northern Trust
12
Northern Trust
Illinois
$92K – – –
AMCA
13
Arthur M. Cohen & Associates
Illinois
$75.5K – – –
TS
14
Tamar Securities
California
$75.4K – – –
FA
15
Fermata Advisors
California
$63.9K +$56.5K +339 New
Osaic Holdings
16
Osaic Holdings
Arizona
$61.2K -$334 -2 -0.6%
Group One Trading
17
Group One Trading
Illinois
$34.3K +$30.4K +182 New
FP
18
Financial Perspectives
Minnesota
$17.7K – – –
Wells Fargo
19
Wells Fargo
California
$11.1K – – –
TRCT
20
Tower Research Capital (TRC)
New York
$113 -$15.2K -91 -99%
NFSG
21
Newbridge Financial Services Group
Florida
$108 – – –
JP Morgan Chase
22
JP Morgan Chase
New York
$59 – – –
UBS Group
23
UBS Group
Switzerland
$5 -$3.17K -19 Closed
Citadel Advisors
24
Citadel Advisors
Florida
– -$139K -1,288 Closed
Squarepoint
25
Squarepoint
New York
– -$40.9K -380 Closed
1
2

NVNO Hedge Fund Activity: Q3 2023 in Review

22 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in enVVeno Medical (NVNO) for Q3 2023, worth a combined $10.4M — up 76% from $5.9M a quarter earlier.

Sellers outnumbered buyers: 4 funds closed out of NVNO and 3 opened new positions — a net loss of 1 holder — while 5 trimmed existing stakes and 4 added.

The largest buyer was UBS O'Connor, adding an estimated $188K. The largest seller was Citadel Advisors, exiting entirely with an estimated $139K sold.

  • 22 institutional investors held enVVeno Medical (NVNO) as of Q3 2023, down from 23 in Q2 2023.
  • Funds reported $10.4M of enVVeno Medical stock for Q3 2023, up 76% quarter-over-quarter.
  • 3 funds opened new enVVeno Medical positions in Q3 2023 and 4 closed out, a net change of -1 holder.
  • The largest enVVeno Medical buyer in Q3 2023 was UBS O'Connor, an estimated $188K added.
  • The largest enVVeno Medical seller in Q3 2023 was Citadel Advisors, an estimated $139K sold.

Based on aggregated 13F filings for Q3 2023.